Helicobacter pylori infection potentiates the inhibition of gastric acid secretion by omeprazole

Gut

Volumn 44, Issue 4, 1999, Pages 468-475

  Gillen, D ^a   Wirz, A A ^a   Neithercut, W D ^b   Ardill, J E S ^c   McColl, K E L ^a  

^a WESTERN INFIRMARY   (United Kingdom)

^b ARROWE PARK HOSPITAL   (United Kingdom)

^c QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

Author keywords

Acid secretion; Ammonia; Helicobacter pylori; Omeprazole

Indexed keywords

AMMONIA; GASTRIN; GASTRIN 17; OMEPRAZOLE; PROTON PUMP INHIBITOR; STOMACH SECRETION INHIBITOR;

ADULT; AMMONIA FORMATION; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; DYSPEPSIA; FEMALE; GASTRIN BLOOD LEVEL; GASTRITIS; GRAM NEGATIVE INFECTION; HELICOBACTER PYLORI; HUMAN; MALE; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; STOMACH ACID SECRETION; STOMACH JUICE; STOMACH PH;

EID: 0032948187     PISSN: 00175749     EISSN: None     Source Type: Journal    
DOI: 10.1136/gut.44.4.468     Document Type: Article

References (64)

1. Olbe L, Haglund U, Leth R, et al. Effect of substituted benzimidazole (H149/94) on gastric acid secretion in humans. Gastroenterology 1981;83:193-8.
2. +)ATPase. Nature 1981;290:159-61.
3. Garner A, Fadlallah H, Parsons M E. 1976 and all that! - 20 years of antisecretory therapy. Gut 1996;39:784-6.
4. Howden CW, Forrest JAH, Reid JL. Effects of single and repeated doses of omeprazole on gastric acid and pepsin secretion in man. Gut 1984;25:707-10.
5. Walt RP, Gomes M de FA, Wood EC, et al. Effect of daily oral omeprazole on 24 hour intragastric acidity. BMJ 1983;287:12-14.
6. Cooperative Study. Omeprazole in duodenal ulceration: acid inhibition, symptom relief, endoscopic healing and recurrence. BMJ 1984;289:525-8.
7. Howden CW, Hunt RH. The relationship between suppression of acidity and gastric ulcer healing rates. Aliment Pharmacol Ther 1990;4:25-33.
8. 2 blocker resistant esophagitis. Dig Dis Sci 1991;36:552-7.
9. Maton PN, Vinayek R, Frucht H, et al. Long term efficacy and safety of omeprazole in patients with Zollinger-Ellison syndrome: a prospective study. Gastroenterology 1989;97:827-36.
10. Marshall BJ, Warren JR. Unidentified curved bacilli in the stomach of patients with gastritis and peptic ulceration. Lancet 1984;i:1311-15.
11. Graham DY. Campylobacter pylori and peptic ulcer. Gastroenterology 1989;96:615-25.
12. Armstrong D. Helicobacter pylori infection and dyspepsia. Scand J Gastroenterol 1996;31(suppl 215):38-47.
13. 13[C]-urea breath test in normal subjects and patients with peptic ulcer. J Infect Dis 1988;157:777-80.
14. McDonagh TA, Woodward M, Morrison C, et al. Lack of independent association of H. pylori and coronary heart disease [abstract]. Gut 1996;38(suppl 1):A1.
15. Bugnoli M, Bayeli PF, Rappuoli O, et al. Inhibition of Helicobacter pylori urease by omeprazole. Eur J Gastroenterol Hepatol 1993;5:683-5.
16. McGowan CC, Cover TL, Blaser MJ. The proton pump inhibitor omeprazole inhibits acid survival of Helicobacter pylori by a urease-independent mechanism. Gastroenterology 1994;107:738-43.
17. Danon SJ, O'Rourke JL, Moss ND, et al. The importance of local acid production in the distribution of Helicobacter felis in the mouse stomach. Gastroenterology 1995;108:1386-95.
18. Logan RPH, Walker MM, Misiewicz JJ, et al. Changes in the intragastric distribution of Helicobacter pylori during treatment with omeprazole. Gut 1995;36:12-16.
19. Kuipers EJ, Uyterlinde AM, Pena AS, et al. Increase of Helicobacter pylori-associated corpus gastritis during acid suppressive therapy: implications for long-term safety. Am J Gastroenterol 1995;90:1401-6.
20. Eissele R, Brunner G, Simon B, et al. Gastric mucosa during drug treatment with lansoprazole: Helicobacter pylori is a risk factor for argyrophil cell hyperplasia. Gastroenterology 1997;112:707-17.
21. Verdu EF, Armstrong D, Fraser R, et al. Effect of Helicobacter pylori status on intragastric pH during treatment with omeprazole. Gut 1995;36:539-43.
22. Verdu EF, Armstrong D, Idstrom J-P, et al. Effect of curing Helicobacter pylori infection on intragastric pH during omeprazole treatment. Gut 1995;37:743-8.
23. Labenz J, Tillenberg B, Peitz U, et al. Helicobacter pylori augments the pH-raising effect of omeprazole in duodenal ulcer patients. Gastroenterology 1996;110:725-32.
24. Koop H, Kuly S, Flug M, et al. Intragastric pH and serum gastrin during administration of different doses of pantoprazole in healthy subjects. Eur J Gastroenterol Hepatol 1996;8:915-18.
25. Ferrero RL, Hazell SL, Lee A. The urease enzymes of Campylobacter pylori and a related bacterium. J Clin Microbiol 1988;27:33-40.
26. 14C urea breath test in determining H. pylori status and predicting ulcer disease in dyspeptic patients. Am J Gastroenterol 1998;93:20-5.
27. Hassan HA, Hobsley M. Positioning of subject and of nasogastric tube during a gastric secretion study. BMJ 1970;i:458-60.
28. Mulholland G, Ardill JES, Fillmore D, et al. Helicobacter pylori-related hypergastrinaemia is due to a selective increase in gastrin-17. Gut 1993;34:757-61.
29. Neithercut WD, El-Nujumi AM, McColl KEL. The measurement of urea and ammonium concentrations in gastric juice. J Clin Pathol 1993;46:462-4.
30. Gillen D, El-Omar E, Wirz, AA, et al. The increased acid response to gastrin which distinguishes H. pylori-infected DU patients from healthy volunteers. Gastroenterology 1998;114:50-7.
31. Fandriks L, Stage L. Simultaneous measurements of gastric motility and acid-bicarbonate secretions in the anaesthetised cat. Acta Physiol Scand 1986;128:563-73.
32. Ladas SD, Katsogridakis J, Malamou H, et al. Helicobacter pylori may induce bile reflux: link between H. pylori and bile induced injury to gastric epithelium. Gut 1996;38:15-18.
33. Yasunaga Y, Shinomura Y, Kanayama S, et al. Improved fold width and increased acid secretion after eradication of the organism in H. pylori-associated enlarged fold gastritis. Gut 1994;35:1571-4.
34. Feldman M, Cryer B, McArthur CE, et al. Effects of aging and gastritis on gastric acid and pepsin secretion in humans: a prospective study. Gastroenterology 1996;110:1043-52.
35. El-Omar EM, Oien K, El-Nujumi A, et al. Helicobacter pylori infection and chronic gastric acid hyposecretion. Gastroenterology 1997;113:15-24.
36. Gutierrez O, Melo M, Graham DY, et al. Improved acid secretion after treatment of H. pylori: time course [abstract]. Gastroenterology 1997;112:A413.
37. Robert A, Olafsson AS, Lancaster C, Zhang W. Interleukin-1 is cytoprotective, antisecretory, stimulates PGE, synthesis by the stomach and retards gastric emptying. Life Sci 1991;48:123-34.
38. Wallace JL, Cucala M, Mugridge K, et al. Secretagogue-specific effects of interleukin-1 on gastric acid secretion. Am J Physiol 1991;261:G559-64.
39. Tach́ Y, Saperas E. Potent inhibition of gastric acid secretion and ulcer formation by centrally and peripherally administered interleukin-1a. Ann NY Acad Sci 1992;664:353-68.
40. Sachs G. Helicobacter pylori and proton pump inhibitors. Gastroenterology 1997;112:1033-5.
41. Lorentzon P, Jackson R, Wallmark B, et al. Inhibition of proton potassium ATPase by omeprazole in isolated gastric vesicles requires proton transport. Biochim Biophys Acta 1987;897:41-51.
42. Cave DR, Vargas M. Effect of a Campylobacter pylori protein on acid secretion by parietal cells. Lancet 1989;ii:187-9.
43. Huang LL, Cave DR, Kane AV. Purification and characterisation of an acid-inhibitory protein from Helicobacter pylori [abstract]. Gastroenterology 1995;108:A839.
44. + ATPase. Gut 1994;35:1176-80.
45. Giannella RA, Broitmans A, Zamcheck N. Gastric acid barrier to ingested micro-organisms: studies in vivo and in vitro. Gut 1972;13:251-6.
46. Drasar BS, Shiner M, McLeod GM. Studies on the intestinal flora: 1. The bacterial flora of the gastrointestinal tract in healthy and achlorhydric persons. Gastroenterology 1969;56:71-9.
47. Hurst AF. The clinical importance of achlorhydria. BMJ 1934;ii:665-9.
48. Boyd JF. Pathology of the alimentary tract in Salmonella typhimurium food poisoning. Gut 1985;26:935-44.
49. Wickramasinghe LSP, Basu SK. Salmonellosis during treatment with ranitidine. BMJ 1984;289:1272.
50. Ruddell WSJ, Losowsky MS. Severe diarrhoea due to small intestinal colonisation during cimetidine treatment. BMJ 1980;281:273.
51. Waddell WR, Kunz LJ. Association of salmonella enteritis with operations on the stomach. N Engl J Med 1956;255:555-9.
52. Axon ATR, Poole D. Salmonellosis presenting with cholera-like diarrhoea. Lancet 1973;i:745-6.
53. Scott HM, Neal KR, Slack RGB, et al. Omeprazole treatment, a potent risk factor for Campylobacter gastroenteritis [abstract]. Gut 1994;35(suppl 1):S30.
54. Williams C, Gillen D, Hossack M, et al. H. pylori infection predisposes to gastric colonisation by other bacteria during omeprazole treatment [abstract]. Gut 1998;42(suppl 1):A3.
55. Correa P. Human gastric carcinogenesis: a multistep and multifactorial process - first American Cancer Society Award Lecture on cancer epidemiology and prevention. Cancer Res 1992;52:6735-40.
56. Klinkenberg-Knol EC, Festen HPM, Jansen JBMJ, et al. Longterm treatment with omeprazole for refractory reflux esophagitis: efficacy and safety. Ann Intern Med 1994;121:161-7.
57. Hetzel DJ, Dent J, Reed WD, et al. Healing and relapse of severe peptic esophagitis after treatment with omeprazole. Gastroenterology 1988;95:903-12.
58. 2-receptor antagonists. Scand J Gastroenterol 1989;24(suppl 66):88-93.
59. 2 receptor antagonists. Aliment Pharm Ther 1990;4:145-55.
60. Zeitoun P, Barbier P, Cayphas JP, et al. Comparison of two dosage regimens of omeprazole - 10mg once daily and 20mg weekends - as prophylaxis against recurrence of reflux esophagitis. Hepatogastroenterology 1989;36:279-80.
61. Bell NJ, Burget D, Howden CW, et al. Appropriate acid suppression for the management of gastro-oesophageal reflux disease. Digestion 1992;51(suppl 1):59-67.
62. Sontag SJ, Hirschowitz BI, Holt S, et al. Two doses of omeprazole versus placebo in symptomatic erosive esophagitis: the US Multicenter Study. Gastroenterology 1992;102:109-18.
63. Vigneri S, Termini R, Leandro G, et al. A comparison of five maintenance therapies for reflux esophagitis. N Engl J Med 1995;333:1106-10.
64. Leite LP, Johnston BT, Just RJ, et al. Persistent acid secretion during omeprazole therapy: a study of gastric acid profiles in patients demonstrating failure of omeprazole therapy. Am J Gastroenterol 1996;91:1527-31.